(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

QUVIVIQ

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

QUVIVIQ

ST13

US500000079274313

Class

5

Filing

79274313

Registration

6166353

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

40

Latest update

08/06/2026

Trademark type

Word

Nice classes

5

Filing date

11/05/2019

Registration date

10/06/2020

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

10/06/2020

Last transaction

08/06/2026

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Drawing code

4

Owner type

25

Owner location

CH

Examiner

LOTT, MAUREEN DALL

Law office

L50

Current location

PUBLICATION AND ISSUE SECTION

Holders and representatives

Holders

Idorsia Pharmaceuticals Ltd
Idorsia Pharmaceuticals Ltd.

Representatives

Mary Margaret L. O'Donnell Blue Filament Law PLLC

Technical classification

Nice Classes

Class 5

Vienna Codes

No Vienna codes available.

Goods and services

Class 5

Pharmaceutical preparations for humans for the prevention and treatment of cardiovascular diseaseshypertensionbrain haemorrhage and sequelae thereofkidney diseasespulmonary diseasesfibrotic diseasescystic fibrosisinflammatory diseasesallergic diseasesauto-immune diseases and disordersneurodegenerative diseases and disordersneurological diseases and disordersdiseases and disorders of the central nervous systemdementiasleep disordersanxiety disordersaddictionseating disordersepilepsymetabolic disordersdiabetesglycolipid storage disordersFabry disease and symptoms and sequelae of Fabry diseaseinfectious diseasescancer

Publications

History of USPTO decisions and trademark events.

40 publications found

RHRD

RESTRICTION OF HOLDER'S RIGHT OF DISPOSAL RECEIVED

08/06/2026

REM3

COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED

10/06/2025

RHRD

RESTRICTION OF HOLDER'S RIGHT OF DISPOSAL RECEIVED

08/22/2025

ADCH

CHANGE OF NAME/ADDRESS REC'D FROM IB

08/16/2024

FINO

FINAL DECISION TRANSACTION PROCESSED BY IB

02/14/2021

FICS

FINAL DISPOSITION NOTICE SENT TO IB

01/23/2021

FIMP

FINAL DISPOSITION PROCESSED

01/23/2021

FICR

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

01/06/2021

NREP

NEW REPRESENTATIVE AT IB RECEIVED

12/11/2020

R.PR

REGISTERED-PRINCIPAL REGISTER

10/06/2020

GPNX

NOTIFICATION PROCESSED BY IB

07/31/2020

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

07/21/2020

PUBO

PUBLISHED FOR OPPOSITION

07/21/2020

OPNS

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB

07/15/2020

OP2R

NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB

07/15/2020

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

07/01/2020

ALIE

ASSIGNED TO LIE

06/15/2020

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

06/12/2020

XAEC

EXAMINER'S AMENDMENT ENTERED

06/12/2020

GNEN

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

06/12/2020

GNEA

EXAMINERS AMENDMENT E-MAILED

06/12/2020

CNEA

EXAMINERS AMENDMENT -WRITTEN

06/12/2020

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

05/23/2020

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

05/22/2020

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

05/22/2020

CHAN

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

05/22/2020

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

05/22/2020

ECDR

TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS

05/22/2020

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

05/22/2020

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

05/22/2020

COAR

TEAS CHANGE OF OWNER ADDRESS RECEIVED

05/22/2020

RFNT

REFUSAL PROCESSED BY IB

03/21/2020

RFCS

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

03/04/2020

RFRR

REFUSAL PROCESSED BY MPU

03/03/2020

RFCR

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

02/09/2020

CNRT

NON-FINAL ACTION WRITTEN

02/08/2020

DOCK

ASSIGNED TO EXAMINER

02/08/2020

MAFR

APPLICATION FILING RECEIPT MAILED

12/24/2019

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

12/20/2019

REPR

SN ASSIGNED FOR SECT 66A APPL FROM IB

12/19/2019

Continuous trademark protection

Get notified about every new filing that threatens QUVIVIQ or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.